From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design
Group
C(yuan)
E (%)
C/E
ΔC/ΔE
The treatment group
41367830.8
45.1
917246.8
The control group
37529823.2
30
1250994.1
254172.7